Skip to content

The Effect of Deep Neuromuscular Blockade on Respiratory Mechanics

The Effect of Deep Neuromuscular Blockade During Robotic Assisted Radical Prostatectomy on Intraoperative Respiratory Mechanics and Postoperative Pulmonary Complications : a Prospective Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04174222
Enrollment
58
Registered
2019-11-22
Start date
2019-11-22
Completion date
2021-06-30
Last updated
2021-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neuromuscular Blockade

Brief summary

This study is a randomized, controlled, double-blinded, and parallel design study. A total 58 patients were randomized to receive a deep block or a moderate block scheduled for elective robot assisted laparoscopic radical prostatectomy. Intraoperative peak inspiratory pressure and plateau pressure are assessed.

Detailed description

Patients \>18 years of age with an america society of anesthesiologist classification of I or II who are scheduled to undergo elective robot assisted laparoscopic radical prostatectomy are included. The exclusion criteria are a history of neuromuscular, renal, or hepatic disease, known allergy to rocuronium or sugammadex. Patients are randomized to either the moderate or deep neuromuscular blockade group using Random Allocation Software (version 1.0). In the operating room, routine monitoring is performed, including electrocardiography, non-invasive arterial pressure measurements, and pulse oximetry. Additionally, acceleromyography are applied to monitor the response of the adductor pollicis muscle. After the induction of anesthesia with propofol and before rocuronium administration, the TOF-Watch-SX is calibrated and stabilised, and a series of train-of-four (TOF) measurements are documented every 1 min. Next, intravenous rocuronium at 0.6 mg/kg was administered, and tracheal intubation was performed after confirmation of relaxation. Anesthesia is maintained with desflurane and target-controlled infusion of remifentanil while monitoring the bispectral index. Intravenous rocuronium (5-10 mg) is used to maintain moderate (TOF count of 1 or 2) or deep (post-tetanic count \[PTC\] of 1 or 2) neuromuscular blockade. Peak inspiratory pressure and plateau pressure are recorded until 1 hour after pneumoperitoneum. At the end of the operation, the surgeon rated the surgical condition on a 5-point scale. Patients are reversed with intravenous sugammadex at 2 or 4 mg/kg. Postoperative pulmonary complications (SpO2 \<100%, RR\<8, atelectasis) are assessed and recorded.

Interventions

Neuromuscular block was maintained at train of four count 1-2.

Neuromuscular block was maintained at train of four count 0 and post-tetanic count1-2.

Sponsors

Seoul National University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients who undergo elective robot assisted radical prostatectomy, * American Society of Anesthesiologists grade 1 or 2

Exclusion criteria

* Refuse to participate to the study * history of neuromuscular diseases * known allergy to rocuronium, sugammadex * patients scheduled for intensive care unit transfer * Body Mass Index \> 30 kg/m2 * Severe renal function impairment * Moderete or severe obstructive/restrictive lung disease

Design outcomes

Primary

MeasureTime frameDescription
Peak inspiratory pressureuntil 1 hour after pneumoperitoneummeasured through ventilator

Secondary

MeasureTime frameDescription
plateau pressureuntil 1 hour after pneumoperitoneummeasured through ventilator
dynamic lung complianceuntil 1 hour after pneumoperitoneumTidal volume/(Peak inspiratory pressure - PEEP)
static lung complianceuntil 1 hour after pneumoperitoneumTidal volume/(Plateau pressure - PEEP)
5-point surgical rating scale1 min at the end of surgeryRated by the surgeon who is in charge of the patient's operation and is blind to the patient's group assignment. (1 = excellent, 2 = good, 3 = acceptable, 4 = poor, 5 = extremely poor)
Postoperative pulmonary complicationspostoperative 30 minSpO2 \<90% or RR \< 8/min, atelectasis confirmed by Chest X ray

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026